Kaerus Bio`s KER-0193 granted Orphan & Rare Pediatric Designation
14 May 2025 //
PR NEWSWIRE
Kaerus Bioscience Completes Phase 1 Trial for Fragile X Syndrome
11 Mar 2025 //
GLOBENEWSWIRE
14 May 2025 //
PR NEWSWIRE
11 Mar 2025 //
GLOBENEWSWIRE